IceCure Medical (ICCM) Free Cash Flow (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Free Cash Flow data on file, last reported at -$4.2 million in Q1 2026.

• On a quarterly basis, Free Cash Flow fell 4.66% year-over-year to -$4.2 million in Q1 2026; TTM through Mar 2026 was -$14.7 million, a 7.49% decrease from a year earlier, with the FY2025 full-year figure at -$14.5 million, down 16.38% from the prior year.
• Free Cash Flow for Q1 2026 stood at -$4.2 million, up from -$5.0 million in the prior quarter.
• Over the last five years, Free Cash Flow for ICCM reached as high as -$2.4 million in Q2 2024 and fell as low as -$5.8 million in Q4 2022.
• Historically, Free Cash Flow has averaged -$3.5 million across 5 years, with a median of -$3.2 million in 2023.
• Across the five-year window, Free Cash Flow slumped 123.12% in 2022 and surged 45.22% in 2023, its largest moves.
• Year by year, Free Cash Flow stood at -$5.8 million in 2022, then jumped by 45.22% to -$3.2 million in 2023, then plunged by 31.64% to -$4.2 million in 2024, then dropped by 19.67% to -$5.0 million in 2025, then climbed by 15.84% to -$4.2 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were -$4.2 million in Q1 2026, -$5.0 million in Q4 2025, and -$2.7 million in Q3 2025.